Generalized Lipodystrophy

Also known as: Generalised Lipodystrophy / Total lipodystrophy / Congenital generalized lipodystrophy / Congenital lipodystrophy / Lipodystrophy congenital / Congenital generalised lipodystrophy / Lawrence-Seip syndrome / Congenital lipoatrophic diabetes / Acquired generalized lipodystrophy (disorder) / Lipodystrophy, Congenital Generalized / Berardinelli-Seip syndrome / Congenital total lipodystrophy (disorder)

DrugDrug NameDrug Description
DB09046MetreleptinA leptin analogue used as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients various forms of lipodystrophy.
DrugDrug NameTargetType
DB09046MetreleptinLeptin receptortarget
DrugDrug NamePhaseStatusCount
DB16673Mibavademab2Active Not Recruiting1
DB09046Metreleptin2 / 3Completed1
DB09046Metreleptin4Active Not Recruiting1